The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease

BACKGROUND : Previously, the inhibition of coronary restenosis with Abciximab (ReoPro(®))-coated stent in a porcine model was reported. ReoPro(®) inhibits platelet aggregation, the proliferation of vascular smooth muscle cells and the inflammatory reaction. METHODS : A prospective randomized trial w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Korean J Intern Med
Glavni autori: Kim, Weon, Jeong, Myung Ho, Hong, Young Joon, Lee, Seng Hyun, Park, Woo Seok, Kim, Ju Han, Kim, In Soo, Choi, Myung Ja, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Cho, Dong Lyun, Kim, Hoon, Kang, Jung Chaee
Format: Artigo
Jezik:Inglês
Izdano: Korean Association of Internal Medicine 2004
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531572/
https://ncbi.nlm.nih.gov/pubmed/15683110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2004.19.4.220
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items